Connor, Clark & Lunn Investment Management Ltd. - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 136 filers reported holding MERSANA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$242,700
-80.1%
59,051
-71.7%
0.00%
-85.7%
Q4 2022$1,221,417
-30.2%
208,433
-19.4%
0.01%
-36.4%
Q3 2022$1,749,000
+8.4%
258,687
+326.8%
0.01%
+10.0%
Q4 2020$1,613,000
-38.6%
60,615
-57.0%
0.01%
-41.2%
Q3 2020$2,626,000
-30.1%
141,024
-12.2%
0.02%
-37.0%
Q2 2020$3,759,000160,6350.03%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$64,810,0006.21%
Bain Capital Life Sciences Investors, LLC 3,695,667$59,796,0003.39%
COMMODORE CAPITAL LP 429,228$6,945,0002.77%
ACUTA CAPITAL PARTNERS, LLC 357,689$5,787,0002.09%
Avoro Capital Advisors LLC 6,800,000$110,024,0001.90%
Ghost Tree Capital, LLC 450,000$7,281,0001.71%
RHO CAPITAL PARTNERS INC 796,458$12,887,0001.24%
Rock Springs Capital Management LP 2,775,127$44,902,0000.98%
Sio Capital Management, LLC 157,259$2,544,0000.52%
Bellevue Group AG 2,850,010$46,113,0000.49%
View complete list of MERSANA THERAPEUTICS INC shareholders